New Developments in Thyroid Cancer
Learning Objectives
At the conclusion of this session, the participant should be able to:
- Integrate into professional practice the key updates of the NCCN Guidelines related to thyroid cancer
Robert I. Haddad, MD
Dana-Farber/Brigham and Women's Cancer Center
Available Credit
- 0.75 Case Manager
- 0.75 Participation
- 0.67 Nurse
- 0.75 Pharmacist
- 0.75 Physician
- 0.50 Tumor Registrar